BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16180215)

  • 1. Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    J Surg Oncol; 2005 Oct; 92(1):70-5. PubMed ID: 16180215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
    Klenova A; Parvanova V; Georgiev R; Gesheva N
    J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age.
    Larsen SG; Wiig JN; Tretli S; Giercksky KE
    Colorectal Dis; 2006 Mar; 8(3):177-85. PubMed ID: 16466556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer.
    Wiig JN; Poulsen JP; Larsen S; Braendengen M; Waehre H; Giercksky KE
    Eur J Surg; 2002; 168(1):42-8. PubMed ID: 12022371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary results of preoperative radiotherapy schedule in the treatment of rectal tumors].
    Corsa P; Parisi S; Canistro A; Raguso A; Fusco V; Troiano M; Bucci F; Mastrodonato N; Tardio B
    Radiol Med; 1997 Dec; 94(6):658-63. PubMed ID: 9524606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer.
    Larsen SG; Wiig JN; Dueland S; Giercksky KE
    Eur J Surg Oncol; 2008 Apr; 34(4):410-7. PubMed ID: 17614249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
    Klenova A; Georgiev R; Kurtev P; Kurteva G
    J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH
    Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of preoperative irradiation in the treatment of rectal adenocarcinoma].
    Gainant A; Roullet B; Cubertafond P; Olivier JP
    Gastroenterol Clin Biol; 1986 Jan; 10(1):17-22. PubMed ID: 3956911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer.
    Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M
    Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
    Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of accelerated preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative prophylactic liver irradiation in patients with locally advanced rectal cancer.
    Suwinski R; Wydmanski J; Pawełczyk I; Starzewski J
    Radiother Oncol; 2006 Jul; 80(1):27-32. PubMed ID: 16730087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in toxicity across gender in patients treated with chemoradiation for rectal cancer.
    Kaminski A; Joseph D; Elsaleh H
    Australas Radiol; 2007 Jun; 51(3):283-8. PubMed ID: 17504322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.